Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches. Guo S, Pelligra C, Saint-Laurent Thibault C, Hernandez L, Kansal A Pharmacoeconomics. 2014 Mar 19. PMID: 24643323. Abstract CommentRecommendBookmarkWatch